Telemetry Investments’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Telemetry Investments’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$362K	Buy	+105,000	New	+$300K	0.57%	46

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Telemetry Investments's GRTS Position: Q4 2022 in Review

Telemetry Investments opened a new position in Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022: 105,000 shares worth $362K. The stake represents 0.57% of the portfolio and ranks #46 among its holdings.

90 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

Telemetry Investments held 105,000 shares of Gritstone bio, Inc. Common Stock worth $362K as of Q4 2022.
Gritstone bio, Inc. Common Stock was a new Telemetry Investments position in Q4 2022.
Gritstone bio, Inc. Common Stock made up 0.57% of Telemetry Investments's portfolio in Q4 2022, its #46 holding.
90 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.